The research suggests that prenatal maternal folate deficiency in early pregnancy has a long-lasting global effect on brain development in offspring and has been associated with smaller total brain volume, poorer language and visuospatial performance in children aged between 6 and 8 years.
Quatrefolic®, as a source of the active form of folate, the (6S)-5-methyltetrahydrofolate (5-MTHF), can be the first choice in the folate supplementation.
Quatrefolic® maximizes the benefit of folate supplementation without incurring in the fruitless effect of other sources of folate, protecting mothers in pregnancy and, according to the study above, young children.
Read more about this study and join our network to stay always up-to-date on the latest news about the world of folates!
Stay connected, it’s easy! Join our network!